IDH2 and astrocytoma (excluding glioblastoma): While IDH mutation is most characteristic of lower-grade infiltrating gliomas, including astrocytomas and oligodendrogliomas, it was in fact the study of GBM that initially led to the discovery of this recurrently altered gene (9).